1. Home
  2. Investing
  3. Stocks
  4. USA
  6. Salarius Pharmaceuticals Inc (SLRX)
  7. Quote


Salarius Pharmaceuticals Stock Price

-0.0252 (-4.0%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 749,352
Bid Price 0.5753
Ask Price 0.6099
News -
Day High 0.6486


52 Week Range


Day Low 0.5565
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Salarius Pharmaceuticals Inc SLRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0252 -4.0% 0.605 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.6219 0.5565 0.6486 0.605 0.6302
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,389 749,352 $ 0.5840712 $ 437,675 - 0.5565 - 3.50
Last Trade Time Type Quantity Stock Price Currency
19:13:40 formt 100 $ 0.605 USD


Draw Mode:

Salarius Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 27.35M 45.21M 45.06M $ 5.23M $ - -0.55 -1.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 11.00k 2.40%

more financials information »

Salarius Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SLRX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.690.720.55650.6398852516,643-0.085-12.32%
1 Month0.800.860.55650.7163568512,760-0.195-24.38%
3 Months1.101.200.55650.9367254684,993-0.495-45.0%
6 Months1.361.490.55651.041,324,619-0.755-55.51%
1 Year0.7353.500.55651.471,667,681-0.13-17.69%
3 Years11.5514.81540.131.46848,019-10.95-94.76%
5 Years11.5514.81540.131.46848,019-10.95-94.76%

Salarius Pharmaceuticals Description

Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing effective treatments for cancers with high, unmet medical need. It is engaged in developing treatments for cancers caused by dysregulated gene expression. The company's lead epigenetic-based technology, seclidemstat (SP-2577) is a small molecule, administered orally, that inhibits the epigenetic enzyme lysine specific demethylase 1.

Your Recent History
Salarius P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.